11 reports

The prevalence rate for FH ranges between one in ## to one in ## people.

  • Statins
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Clinical Trial profile. 1201 Trial Title
  • 5. All the trials included are unique trials.
  • Clinical Trial
  • Lipid Modifying Drug
  • Pharmaceutical
  • Statins
  • World
  • Target
  • Clinical Trial profile. 240 Trial Title
  • Cholesterol
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World
  • Target
  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World
  • Target
  • Cardiovascular Disease
  • Lipid Modifying Drug
  • Pharmaceutical
  • Statins
  • World
  • 9.4.2 PERCENT DRUG-TREATED PATIENTS

Competitive Assessment MAJOR FISH OIL-DERIVED OMEGA-##S: EICOSAPENTAENOIC ACID (EPA) AND DOCOSAHEXAENOIC ACID (DHA).

  • Statins
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

Omega-##-Carboxylic Acids is a complex mixture of concentrated omega-## free fatty acids purified from crude marine fish oil.

  • Endocrine Disease
  • Statins
  • United States
  • Company
  • Product Initiative
  • 8.1.1 FORECAST
  • 9.4.2 PERCENT DRUG-TREATED PATIENTS

EZETIMIBE CONTRIBUTED ##% ($##M), LEAVING ABOUT ##. ##% TO THE OMEGA-## FISH OIL DRUGS ($##M).

  • Statins
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 9.4.2 PERCENT DRUG-TREATED PATIENTS

Competitive Assessment MAJOR FISH OIL-DERIVED OMEGA-##S: EICOSAPENTAENOIC ACID (EPA) AND DOCOSAHEXAENOIC ACID (DHA).

  • Statins
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 9.4.2 PERCENT DRUG-TREATED PATIENTS

Competitive Assessment MAJOR FISH OIL-DERIVED OMEGA-##S: EICOSAPENTAENOIC ACID (EPA) AND DOCOSAHEXAENOIC ACID (DHA).

  • Statins
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.